BRCA1 and neoplasm: PARPis enhance the efficacy of radiotherapy and chemotherapy with alkylating agents and platinum containing drugs via interrupting DNA single strand repairs and promoting tumor cells apoptosis through the mechanism that PARPis can block the alternative DNA repair pathway of BRCA1/2 mutated tumor cells resulting in synthetic lethality (Gong et al., 2020).